EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Impact of Late Gadolinium Enhancement on Major Adverse Cardiovascular Events and Time‐Varying Attenuation of Risk in Dilated Cardiomyopathy

Liyuan Ma iD, Yuan Li, Huairong Zhang, Yan Zheng, Pei Wang, Yuanyuan Niu, Li Zhu iD

Clinical Cardiology · 2026-11 · 49 (11)

DOI: 10.1002/clc.70506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Cardiology, online erschienen am 29.10.2026. Verfasst von Liyuan Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: General Hospital of Ningxia Medical University, Yinchuan, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Magnetic Resonance Imaging, Cine, Contrast Media, Gadolinium. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yinchuan Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate the prognostic value of late gadolinium enhancement (LGE) extent for major adverse cardiovascular events (MACE) in dilated cardiomyopathy (DCM) patients and characterize the dynamic pattern of its risk effect over time.

Methods

We retrospectively enrolled patients who underwent Cardiac Magnetic Resonance (CMR) between 2020 and 2024, with MACE (cardiac death, heart failure re‐hospitalization, or sustained ventricular arrhythmia) as the endpoint. Patients were stratified by MACE occurrence. Schoenfeld residual testing showed borderline deviation of the proportional hazards (PH) assumption for LGE extent (LV mass percentage). Thus, a time‐dependent Cox model (Extended Cox PHs Model) with an LGE extent × follow‐up time interaction term was built to assess dynamic hazard ratio changes, and independent MACE risk factors were identified.

Results

Among 173 DCM patients (age 47 ± 15 years, 105 males), 46 (26.6%) experienced MACE after a mean follow‐up of 27 ± 16 months. The time‐dependent Cox model identified LGE extent (baseline HR: 1.243, 95% CI: 1.162–1.329, p < 0.001), the LGE extent × time interaction (HR: 0.993, 95% CI: 0.989–0.997, p = 0.001), and LV end‐diastolic volume index (LVEDVi; HR = 1.008, 95% CI: 1.003–1.014, p = 0.001) as independent MACE predictors. Notably, the risk effect of LGE extent demonstrated time‐dependent attenuation.

Conclusion

LV LGE extent and LVEDVi independently predict MACE in DCM patients. The early prognostic value of LGE extent suggests a critical time window for early fibrosis intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, DilatedMagnetic Resonance Imaging, CineContrast MediaGadoliniumVentricular Function, LeftHumansPrognosisRetrospective StudiesMaleFemaleTime FactorsMiddle AgedRisk FactorsRisk AssessmentFollow-Up Studies

Stichwörter der Autor:innen

cardiovascular magnetic resonancedilated cardiomyopathylate gadolinium enhancementprognosis

Substanzen

Contrast MediaGadolinium

Autor:innen und Institutionen

  • General Hospital of Ningxia Medical University, Yinchuan, China.
  • The First Clinical Medical College of Ningxia Medical University, Yinchuan, China.
  • Department of Radiology, General Hospital of Ningxia Medical University, Yinchuan, China.

ORCID-Profile: Liyuan Ma, Li Zhu

Förderung

  • Yinchuan Science and Technology Plan Project

Zitieren

APA

Ma, L., Li, Y., Zhang, H., Zheng, Y., Wang, P., Niu, Y., & Zhu, L. (2026). Prognostic Impact of Late Gadolinium Enhancement on Major Adverse Cardiovascular Events and Time‐Varying Attenuation of Risk in Dilated Cardiomyopathy. Clinical Cardiology, 49(11). https://doi.org/10.1002/clc.70506

Vancouver

Ma L, Li Y, Zhang H, Zheng Y, Wang P, Niu Y, et al. Prognostic Impact of Late Gadolinium Enhancement on Major Adverse Cardiovascular Events and Time‐Varying Attenuation of Risk in Dilated Cardiomyopathy. Clinical Cardiology. 2026;49(11). doi:10.1002/clc.70506

BibTeX
@article{Ma2026,
  author = {Ma, Liyuan and Li, Yuan and Zhang, Huairong and Zheng, Yan and Wang, Pei and Niu, Yuanyuan and Zhu, Li},
  title = {Prognostic Impact of Late Gadolinium Enhancement on Major Adverse Cardiovascular Events and Time‐Varying Attenuation of Risk in Dilated Cardiomyopathy},
  journal = {Clinical Cardiology},
  year = {2026},
  volume = {49},
  number = {11},
  doi = {10.1002/clc.70506}
}
Kostenlos starten →